ONO 3708: A New Thromboxane A2 Receptor Antagonist
暂无分享,去创建一个
[1] L. Rubin,et al. Role of venoconstriction in thromboxane-induced pulmonary hypertension and edema in lambs. , 1989, Journal of applied physiology.
[2] N. Toda,et al. Role of endothelium in the response to prostaglandin H2 in isolated dog arteries. , 1989, Japanese journal of pharmacology.
[3] N. Toda,et al. Endothelium-dependent and -independent responses to vasodilators of isolated dog cerebral arteries. , 1988, Stroke.
[4] N. Toda,et al. Endothelium-dependent and independent responses to prostaglandin H2 and arachidonic acid in isolated dog cerebral arteries. , 1988, The Journal of pharmacology and experimental therapeutics.
[5] D. Underwood,et al. Effects of OKY 1581 on bronchoconstrictor responses to arachidonic acid and PGH2. , 1987, Journal of applied physiology.
[6] M. Miyazaki,et al. Interactions of thromboxane A2 analogs and prostaglandins in isolated dog arteries. , 1986, Journal of cardiovascular pharmacology.
[7] G. Zimmerman,et al. Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. , 1985, The Journal of clinical investigation.
[8] A. M. Lefer,et al. Anti-ischemic actions of a new thromboxane receptor antagonist during acute myocardial ischemia in cats. , 1985, American heart journal.
[9] R. Armstrong,et al. Effect of the thromboxane receptor antagonist EP 092 on endotoxin shock in the sheep. , 1985, Prostaglandins.
[10] P. Halushka,et al. Protective Effects of trans‐13-APT, a Thromboxane Receptor Antagonist, in Endotoxemia , 1985, Journal of cardiovascular pharmacology.
[11] R. Korthuis,et al. Effects of arachidonate on permeability and resistance distribution in canine lungs. , 1985, Journal of applied physiology.
[12] A. M. Lefer,et al. Preservation of ischemic myocardial tissue with an antagonist of vasoconstrictor eicosanoids. , 1984, Canadian journal of physiology and pharmacology.
[13] J. Snapper,et al. Effects of cyclooxygenase inhibitors on the alterations in lung mechanics caused by endotoxemia in the unanesthetized sheep. , 1983, The Journal of clinical investigation.
[14] P. Halushka,et al. Effects of a pyridine derivative thromboxane synthetase inhibitor and its inactive isomer in endotoxic shock in the rat , 1983, British journal of pharmacology.
[15] E. Macarak,et al. Bovine endothelial cells in culture produce thromboxane as well as prostacyclin. , 1981, The Journal of clinical investigation.
[16] J. Tainer,et al. Biogenesis of chemotactic molecules by the arachidonate lipoxygenase system of platelets , 1975, Nature.
[17] M. Hamberg,et al. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. , 1975, Proceedings of the National Academy of Sciences of the United States of America.